QLT, Inc. recently announced it intended to stop investing in new products and technologies and would instead explore all strategic alternatives including selling the company to a third party.

DelScience's company profile report will provide the information and analysis you need on QLT to gain an understanding of what made the company one of the drug delivery market leaders in the past, and what led it to the current situation. 

The QLT company profile contains updated information on company details, management profiles, milestones, product pipeline, marketed portfolio, proprietary technologies, product revenues and financial data.

The full report is available to download in pdf format in our Services section, under Nanomedicine and Drug Delivery Reports. Should you be interested in more information regarding the report, please do not hesitate to email us at This e-mail address is being protected from spam bots, you need JavaScript enabled to view it .